Manifestaciones cardiovasculares de las enfermedades reumatológicas sistémicas
Resumen
Las enfermedades reumatológicas sistémicas se caracterizan por una enorme y variada cantidad manifestaciones clínicas. En relación a las manifestaciones cardiovasculares, destaca por un lado el fenómeno de ateroesclerosis acelerada con las consecuencias respectivas a nivel miocárdico y por otro, la afectación cardíaca primaria, la cual puede comprometer a todas las estructuras del corazón, con claros matices según la enfermedad específica. El compromiso cardiovascular es de suma relevancia en cuanto tiene una directa repercusión en la morbimortalidad de estos enfermos y por ello debe tenerse en cuenta en la evaluación de todo paciente con estas patologías. La presente revisión tiene como objetivo describir las manifestaciones cardiovasculares en las enfermedades reumatológicas sistémicas más importantes.Palabras clave:
enfermedades reumatológicas, ateroesclerosis, enfermedades cardiovascularesReferencias
(1) Castañeda S, Nurmohamed M, Gonzalez-Gay M. Cardiovascular disease in inflammatory rheumatic diseases. Best Pract Res Clin Rheumatol. 2016; 30(5): 851-869.
(2) Castañeda S, Martín-Martínez MA, Gonzalez-Juanatey C, et al. CARMA Project Collaborative Group. Cardiovascular morbidity and associated risk factors in Spanish patients with chronic inflammatory rheumatic diseases attending rheumatology clinics: baseline data of the CARMA Project. Semin Arthritis Rheum. 2015; 44: 618e26.
(3) Agca R, Heslinga SC, van Halm VP, et al. Atherosclerotic cardiovascular disease in patients with chronic inflammatory joint disorders. Heart 2016; 102: 790-795.
(4) Sarzi-Puttini P, Atzeni F, Gerli R, Bartoloni E, Doria A, Barskova T, Matucci-Cerinic M, Sitia S, Tomasoni L, Turiel M. Cardiac involvement in systemic rheumatic diseases: An update. Autoimmun Rev. 2010; 9(12): 849-52.
(5) Turiel M, Sitia S, Atzeni F, Tomasoni L, Gianturco L, Giuffrida M, De Gennaro Colonna V, Sarzi-Puttini P.The heart in rheumatoid arthritis. Autoimmun Rev. 2010; 9(6): 414-8.
(6) Prati C, Claudepierre P, Pham T, Wendling D. Mortality in spondylarthritis. Jt Bone Spine. 2011; 78: 466e70.
(7) Dauden E, Castañeda S, Suarez C, et al., Working Group on Comorbidity in Psoriasis. Clinical practice guideline for an integrated approach to comorbidity in patients with psoriasis. J Eur Acad Dermatol Venereol. 2013; 27: 1387e404.
(8) Ho HH, Yeh SJ, Tsai WP, Wang CM, Chen JY. Paroxysmal supraventricular tachycardia and Wolff- Parkinson-White syndrome in ankylosing spondylitis: a large cohort observation study and literature review. Semin Arthritis Rheum. 2012; 42(3): 246-53.
(9) Wu GC, Liu HR, Leng RX, Li XP, Li XM, Pan HF, Ye DQ. Subclinical atherosclerosis in patients with systemic lupus erythematosus: A systemic review and meta-analysis. Autoimmun Rev. 2016; 15(1): 22-37.
(10) Belibou C, Ancuta C, Ancuta E, Filos C, Chirieac R. Carotid intima–media thickness and plaque as surrogate biomarkers of atherosclerosis among consecutive women with systemic lupus erythematosus. Rom J Morphol Embryol. 2012; 53: 29-34.
(11) Frieri M, Stampfl H. Systemic lupus erythematosus and atherosclerosis: Review of the literature. Autoimmun Rev. 2016; 15(1): 16-21.
(12) Chen J, Tang Y, Zhu M, Xu A. Heart involvement in systemic lupus erythematosus: a systemic review and meta- analysis. Clin Rheumatol. 2016; 35: 2437-2448.
(13) Mirfeizi Z, Poorzand H, Javanbakht A, Khajedaluee M. Relationship Between Systemic Lupus Erythematosus Disease Activity Index Scores and Subclinical Cardiac Problems. Iran Red Crescent Med J. 2016; 18(8): e38045.
(14) Seferović PM, Ristić AD, Maksimović R, Simeunović DS, Ristić GG, Radovanović G, Seferović D, Maisch B, Matucci-Cerinic M. Cardiac arrhythmias and conduction disturbances in autoimmune rheumatic diseases. Rheumatology. 2006; 45(Suppl 4): 39-42.
(15) Amigo MC. What do we know about the cardiac valve lesion in the antiphospholipid syndrome (APS)?. Lupus. 2014; 23(12): 1259-61.
(16) Valim V, Gerdts E, Jonsson R, Ferreira GA, Brokstad KA, Brun JG, Midtbø H, Mydel PM. Atherosclerosis in Sjögren's syndrome: evidence, possible mechanisms and knowledge gaps. Clin Exp Rheumatol. 2016; 34(1): 133-42.
(17) Psarras A, Soulaidopoulos S, Garyfallos A, Kitas G, Dimitroulas T. A critical view on cardiovascular risk in systemic sclerosis. Rheumatol Int. 2017; 37(1): 85-95.
(18) Fernández-Codina A, Simeón-Aznar CP, Pinal- Fernandez I, Rodríguez-Palomares J, Pizzi MN, Hidalgo CE, Del Castillo AG, Prado-Galbarro FJ, Sarria- Santamera A, Fonollosa-Plà V, Vilardell-Tarrés M. Cardiac involvement in systemic sclerosis: differences between clinical subsets and influence on survival. Rheumatol Int. 2017; 37(1): 75-84.
(19) Rosato E, Tubani L, Gigante A. QTc interval prolongation in systemic sclerosis [carta al editor]. International Journal of Cardiology. 2017; 239: 34.
(20) Schwartz T, Diederichsen LP, Lundberg IE, Sjaastad I, Sanner H. Cardiac involvement in adult and juvenile idiopathic inflammatory myopathies. RMD Open. 2016; 2(2): e000291.
(21) Rosenbohm A, Buckert D, Gerischer N, et al. Early diagnosis of cardiac involvement in idiopathic inflammatory myopathy by cardiac magnetic resonance tomography. J Neurol. 2015; 262: 949-56.
(22) Rav-Acha M, Plot L, Peled N, Amital H. Coronary involvement in Takayasu's arteritis. Autoimmun Rev. 2007; 6(8): 566-71.
(23) Wang X, Dang A, Lv N, Cheng N, Cheng X, Yang Y, Song Y. Long-term outcomes of coronary artery bypass grafting versus percutaneous coronary intervention for Takayasu arteritis patients with coronary artery involvement. Semin Arthritis Rheum. 2017; 47(2): 247-252.
(24) Brucato A, Maestroni S, Masciocco G, Ammirati E, Bonacina E, Pedrotti P. Cardiac involvement in Churg- Strauss síndrome. G Ital Cardiol. 2015; 16(9): 493-500.
(25) Pagnoux C, Guillevin L. Cardiac involvement in small and medium-sized vessel vasculitides. Lupus. 2005; 14(9): 718-22.
(26) Castelein T, Coudyzer W, Blockmans D. IgG4- related periaortitis vs idiopathic periaortitis: is there a role for atherosclerotic plaque in the pathogenesis of IgG4- related periaortitis?. Rheumatology. 2015; 54(7): 1250-6.
(27) Mori K, Yamada K, Konno T, Inoue D, Uno Y, Watanabe M, Okuda M, Oe K, Kawano M, Yamagishi M. Pericardial Involvement in IgG4-related Disease. Intern Med. 2015; 54(10): 1231-5.
(28) Seo J, Song IJ, Lee S, Jeong HJ, Kim HM, Koh BS, Park SH. A Case of Constrictive Pericarditis due to Immunoglobulin G4-Related Disease. Korean Circ J. 2015; 45(2): 161-4.
(29) Stone JH, Zen Y, Deshpande V. IgG4-related disease. N Engl J Med. 2012; 366(6): 539-51.
(30) Agca R, Heslinga SC, Rollefstad S, Heslinga M, McInnes IB, Peters MJ, Kvien TK, Dougados M, Radner H, Atzeni F, Primdahl J, Södergren A, Wallberg Jonsson S, van Rompay J, Zabalan C, Pedersen TR, Jacobsson L, de Vlam K, Gonzalez-Gay MA, Semb AG, Kitas GD, Smulders YM, Szekanecz Z, Sattar N, Symmons DP, Nurmohamed MT. EULAR recommendations for cardiovascular disease risk management in patients with rheumatoid arthritis and other forms of inflammatory joint disorders: 2015/2016 update. Ann Rheum Dis. 2017; 76(1): 17-28.
